Relative Cost Effectiveness of Depo-Provera ® , Implanon ® , and Mirena ® in Reversible Long-Term Hormonal Contraception in the UK

Author： Susan J. Varney   Julian F. Guest  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.22, Iss.17, 2004-01, pp. : 1141-1151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Analysis of Long Term Reversible Contraceptives: Focus on Implanon

By Phillips C.J.  

PharmacoEconomics, Vol. 17, Iss. 2, 2000-02 ,pp. : 209-221

Adis International

Access to resources Recommend Favorite

Economic Analysis of Long Term Reversible Contraceptives: Focus on Implanon

By Rissanen P.  

PharmacoEconomics, Vol. 18, Iss. 5, 2000-11 ,pp. : 511-513

Adis International

Access to resources Recommend Favorite

Depo-Provera may cause loss of bone mineral density

By  

Reactions Weekly, Vol. 1, Iss. 1059, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Canadian Depo-Provera label updated with risk of BMD loss

By  

Reactions Weekly, Vol. 1, Iss. 1060, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Updated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer: A UK Perspective Considering Duration of Benefit, Long-Term Toxicity and Pattern of Recurrence

By Hall Peter S.   Hulme Claire   McCabe Christopher   Oluboyede Yemi   Round Jeff   Cameron David A.  

PharmacoEconomics, Vol. 29, Iss. 5, 2011-05 ,pp. : 415-432

Adis International

Access to resources Recommend Favorite